Evidence map›Paper›PMID 30815066›Full record

ArticleAMIA ... Annual Symposium proceedings. AMIA Symposium2018

Developing User Personas to Aid in the Design of a User-Centered Natural Product-Drug Interaction Information Resource for Researchers.

Richard D Boyce, Isabelle Ragueneau-Majlessi, Jingjing Yu, Jessica Tay-Sontheimer, Chris Kinsella, Eric Chou, Mathias Brochhausen, John Judkins, Brandon T Gufford, Bruce E Pinkleton and 3 more

Open access · greenAbstract read
In one paragraph

Article in AMIA ... Annual Symposium proceedings. AMIA Symposium, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
0.4field-weighted citation impact, top 35% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 3 citations in OpenAlex.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors at 5 institutions in 1 country.

Richard D BoyceUniversity of Pittsburgh, PA.
Isabelle Ragueneau-MajlessiUniversity of Washington, Seattle, WA.
Jingjing YuUniversity of Washington, Seattle, WA.
Jessica Tay-SontheimerUniversity of Washington, Seattle, WA.
Chris KinsellaUniversity of Washington, Seattle, WA.
Eric ChouUniversity of Pittsburgh, PA.
Mathias BrochhausenUniversity of Arkansas for Medical Sciences, Little Rock, AR.
John JudkinsUniversity of Arkansas for Medical Sciences, Little Rock, AR.
Brandon T GuffordIndiana University School of Medicine, Indianapolis, IN.
Bruce E PinkletonWashington State University, Pullman and Spokane, WA.
Rebecca CooneyWashington State University, Pullman and Spokane, WA.
Mary F PaineWashington State University, Pullman and Spokane, WA.
Jeannine S McCuneCity of Hope Comprehensive Cancer Center, Duarte, CA.
University of Washington · USUniversity of Arkansas for Medical Sciences · USUniversity of Pittsburgh · USCity of Hope · USIndiana University – Purdue University Indianapolis · US

Funding

Pharmacology CoreU54AT008909 · NCCIH · WASHINGTON STATE UNIVERSITY · PI PAINE, MARY F · 2015 to 2024
$22.4M
NCCIH NIH HHS U54 AT008909
6 · The paper itself

Abstract

Pharmacokinetic interactions between natural products and conventional drugs can adversely impact patient outcomes. These complex interactions present unique challenges that require clear communication to researchers. We are creating a public information portal to facilitate researchers' access to credible evidence about these interactions. As part of a user-centered design process, three types of intended researchers were surveyed: drug-drug interaction scientists, clinical pharmacists, and drug compendium editors. Of the 23 invited researchers, 17 completed the survey. The researchers suggested a number of specific requirements for a natural product-drug interaction information resource, including specific information about a given interaction, the potential to cause adverse effects, and the clinical importance. Results were used to develop user personas that provided the development team with a concise and memorable way to represent information needs of the three main researcher types and a common basis for communicating the design's rationale.

Indexed as

Biological ProductsDatabases, FactualHerb-Drug InteractionsPharmacistsResearch PersonnelAccess to InformationHumansNational Center for Complementary and Integrative Health (U.S.)Pharmacopoeias as TopicUnited StatesBiological Products

Identifiers

PMID30815066
PMCPMC6371317
OpenAlexW2941516514

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.